Publications by Terese K. Haaland
19 publications found
Original articles
Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas
Mol Oncol, 9 (4), 758-71
DOI 10.1016/j.molonc.2014.12.002, PubMed 25579086
Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease
Med Ultrason, 15 (1), 16-22
DOI 10.11152/mu.2013.2066.151.hlv1qmu2, PubMed 23486619
Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver
Scand J Gastroenterol, 48 (1), 93-100
DOI 10.3109/00365521.2012.746389, PubMed 23205894
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol, 166 (3), 503-10
DOI 10.1530/EJE-11-0864, PubMed 22170794
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
DOI 10.1210/jc.2009-2148, PubMed 20392873
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130
Gene expression profiles reflect sclerosing cholangitis activity in abcb4 (-/-) mice
Scand J Gastroenterol, 44 (2), 211-8
DOI 10.1080/00365520802400867, PubMed 18785065
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343
Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/ - ) mice harbouring chronic cholangitis
Scand J Gastroenterol, 42 (10), 1245-55
DOI 10.1080/00365520701320521, PubMed 17852852
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
DOI 10.1016/j.jhep.2006.02.011, PubMed 16618517
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Scand J Gastroenterol, 40 (12), 1469-77
DOI 10.1080/00365520500264953, PubMed 16293559
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia
QJM, 92 (8), 433-41
DOI 10.1093/qjmed/92.8.433, PubMed 10627859
The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia
J Intern Med, 245 (5), 517-24
DOI 10.1046/j.1365-2796.1999.00457.x, PubMed 10363753
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia
Scand J Infect Dis, 30 (5), 520-2
DOI 10.1080/00365549850161575, PubMed 10066058
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
Hepatology, 23 (6), 1369-76
DOI 10.1002/hep.510230612, PubMed 8675153
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
N Engl J Med, 331 (24), 1607-11
DOI 10.1056/NEJM199412153312402, PubMed 7526215
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis
Scand J Gastroenterol, 29 (8), 744-52
DOI 10.3109/00365529409092504, PubMed 7973436
Intraoperative prediction of ischaemic injury of the bowel: a comparison of laser Doppler flowmetry and tissue oximetry to histological analysis
Eur J Vasc Surg, 6 (5), 518-24
DOI 10.1016/s0950-821x(05)80627-9, PubMed 1397347
Review articles
Bureaucracy, politics and situationalism. Norwegian state history 1814-1900
Hist. Tidsskr., 79 (1), 53-95